Neil Desai
PhD
Chief Scientific Officer
👥Biography 个人简介
Neil Desai co-invented nab-technology, the nanoparticle albumin-bound formulation platform that enabled development of Abraxane (nab-paclitaxel). He contributed to clinical development of Abraxane across metastatic breast, NSCLC, and pancreatic cancer, including the MPACT trial demonstrating improved outcomes versus gemcitabine alone. He has continued nab-technology development with nab-rapamycin (FYARRO) for malignant perivascular epithelioid cell tumors.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Neil Desai 的研究动态
Follow Neil Desai's research updates
留下邮箱，当我们发布与 Neil Desai（Aadi Biosciences）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment